Attila Zalatnai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Attila Zalatnai has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Andras Bibok
Department of Interventional Radiology, Heart and Vascular Centre, Semmelweis University, Határőr út 18, H-1122 Budapest, Hungary
1 shared publication - Andrea Balogh
Institute of Translational Medicine, Semmelweis University, 1094 Budapest, Hungary
1 shared publication Attila Szabó
Borsod-Abaúj-Zemplén Vármegyei Központi Kórház, II. sz. Belgyógyászati osztály
1 shared publicationBrigitta Szolga
Semmelweis Egyetem, Sebészeti, Transzplantációs és Gasztroenterológiai Klinika, Belgyógyászati és Onkológiai Klinika
1 shared publicationBéla Szende
Department of Pathology and Experimental Cancer Research, Semmelweis University Budapest, Budapest, Hungary
1 shared publication- Erik Bényei
Semmelweis Egyetem Belgyógyászati és Onkológiai Klinika
1 shared publication
Latest Publications
- Open Access
- 16 October 2025
- Published by Medicina Könyvkiadó in Magyar Belorvosi Archívum
- Vol. 78 (4) , 214-217
Teljes Gastrectomiát követő nem insulinomás pancreatogen hypoglykaemia szindróma 20 éves kórtörténete
A felnőttkori nem insulinomás pancreatogen hypoglykaemia a hyperinsulinaemiás hypoglykaemiák egyik ritka formája. A kórkép tumorszindrómák részeként fordulhat elő, illetve bariátriai sebészeti műtétek következtében alakulhat ki. A klinikai megjelenés nagyon hasonlít az insulinomához, az elkülönítő kórisme és a kezelés napjainkban is kihívást jelent.
- 16 October 2025
- Published by Medicina Könyvkiadó in Magyar Belorvosi Archívum
- Vol. 78 (4) , 214-217
Open AccessTeljes Gastrectomiát követő nem insulinomás pancreatogen hypoglykaemia szindróma 20 éves kórtörténete
A felnőttkori nem insulinomás pancreatogen hypoglykaemia a hyperinsulinaemiás hypoglykaemiák egyik ritka formája. A kórkép tumorszindrómák részeként fordulhat elő, illetve bariátriai sebészeti műtétek következtében alakulhat ki. A klinikai megjelenés nagyon hasonlít az insulinomához, az elkülönítő kórisme és a kezelés napjainkban is kihívást jelent.
- Open Access
- 15 May 2023
- Published by Frontiers Media SA in Pathology and Oncology Research
- Vol. 29, 1610905
Correlations between the histopathological alterations in minor salivary glands and the clinically suspected Sjögren’s syndrome
In sicca syndrome patients the xerostomia, xerophthalmia and the serological findings may strongly suggest the autoimmune Sjögren’s syndrome, but the histological findings in the labial salivary gland biopsies do not always justify the suspected diagnosis. The aim of this study was to compare the histomorphological changes and the clinical findings in patients with pathologically established Sjögren’s syndrome and in cases with negative histology. A total of 133 labial biopsies have been retrospectively evaluated from 2015 to May 2022, and the characteristic Sjögren’s lesions were found in 67 cases. According to the clinical data, 34 cases proved to be primary, and 33 were associated (“secondary”) forms. In 66 cases, the histology did not justify Sjögren’s syndrome; a significant acinar loss, fibrolipomatous infiltration, and mild sialadenitis had led to the clinical symptoms. In Sjögren’s histologies, the acinar loss was detected in just 31.8% of cases, which might indicate that the diminished saliva production represents immune-mediated hypofunction rather than direct damage of the acini. This is the first systemic study in Hungary investigating the correlation between pathological alterations and clinical findings.
- 15 May 2023
- Published by Frontiers Media SA in Pathology and Oncology Research
- Vol. 29, 1610905
Open AccessCorrelations between the histopathological alterations in minor salivary glands and the clinically suspected Sjögren’s syndrome
In sicca syndrome patients the xerostomia, xerophthalmia and the serological findings may strongly suggest the autoimmune Sjögren’s syndrome, but the histological findings in the labial salivary gland biopsies do not always justify the suspected diagnosis. The aim of this study was to compare the histomorphological changes and the clinical findings in patients with pathologically established Sjögren’s syndrome and in cases with negative histology. A total of 133 labial biopsies have been retrospectively evaluated from 2015 to May 2022, and the characteristic Sjögren’s lesions were found in 67 cases. According to the clinical data, 34 cases proved to be primary, and 33 were associated (“secondary”) forms. In 66 cases, the histology did not justify Sjögren’s syndrome; a significant acinar loss, fibrolipomatous infiltration, and mild sialadenitis had led to the clinical symptoms. In Sjögren’s histologies, the acinar loss was detected in just 31.8% of cases, which might indicate that the diminished saliva production represents immune-mediated hypofunction rather than direct damage of the acini. This is the first systemic study in Hungary investigating the correlation between pathological alterations and clinical findings.
- Open Access
- 28 August 2022
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 163 (35) , 1409-1412
Igazgyöngy pancreasban? Myxoglobulosis különleges esete
A szerzők pancreasfej-carcinoma és egy tőle független, szimpla mucinosus cysta együttes előfordulását ismertetik, az utóbbiban myxoglobulosis kialakulásával. Myxoglobulosis leginkább az appendix mucokelében felhalmozódott nyák szerkezeti megváltozásával alakul ki; ritkán oralis mucokelékben is közöltek eseteket, de pancreasban ez az első eset az irodalomban. Orv Hetil. 2022; 163(35): 1409–1412.
- 28 August 2022
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 163 (35) , 1409-1412
Open AccessIgazgyöngy pancreasban? Myxoglobulosis különleges esete
A szerzők pancreasfej-carcinoma és egy tőle független, szimpla mucinosus cysta együttes előfordulását ismertetik, az utóbbiban myxoglobulosis kialakulásával. Myxoglobulosis leginkább az appendix mucokelében felhalmozódott nyák szerkezeti megváltozásával alakul ki; ritkán oralis mucokelékben is közöltek eseteket, de pancreasban ez az első eset az irodalomban. Orv Hetil. 2022; 163(35): 1409–1412.
- Open Access
- 14 April 2021
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 171 (9-10) , 221-225
Academic relationships between Hungarian professors and the Second Vienna Medical School
Summary: This article discusses the impact of the ‘second’ Vienna Medical School, hallmarked by Karl Rokitansky, Joseph Skoda and Ferdinand Hebra, on the study and practice of medicine in Hungary. Six medical doctors’ lives and achievements are outlined, who formed a bridge between Vienna and Budapest through their studies and work. Four of them returned to Hungary and promoted the cause of medicine and medical education there. Lajos Arányi (1812–1877) founded in 1844 the Institute of Pathology at the University of Pest. János Balassa (1814–1868) took the Chair of the Surgical Department. Ignaz Philip Semmelweis (1818–1865), the ‘Saviour of Mothers’, received a position at the Department of Obstetrics and Gynaecology in Vienna in 1846. Gustav Scheuthauer (1832–1894) became Arányi’s successor. Each of them continued to keep contact with their tutors in Vienna, especially with Karl Rokitansky, and followed the clinicopathological conception pioneered by the Vienna Medical School regarding diagnostics, treatment and prevention of diseases. Two physicians remained in Vienna: Mór Kaposi (1837–1902), who became known worldwide posthumously due to the connection between Kaposi’s sarcoma and AIDS, was the director of the Department of Dermatology of the Vienna University in 1878. Salomon Stricker (1837–1898) undertook the leadership of the Department of General and Experimental Pathology in 1872.
- 14 April 2021
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 171 (9-10) , 221-225
Open AccessAcademic relationships between Hungarian professors and the Second Vienna Medical School
Summary: This article discusses the impact of the ‘second’ Vienna Medical School, hallmarked by Karl Rokitansky, Joseph Skoda and Ferdinand Hebra, on the study and practice of medicine in Hungary. Six medical doctors’ lives and achievements are outlined, who formed a bridge between Vienna and Budapest through their studies and work. Four of them returned to Hungary and promoted the cause of medicine and medical education there. Lajos Arányi (1812–1877) founded in 1844 the Institute of Pathology at the University of Pest. János Balassa (1814–1868) took the Chair of the Surgical Department. Ignaz Philip Semmelweis (1818–1865), the ‘Saviour of Mothers’, received a position at the Department of Obstetrics and Gynaecology in Vienna in 1846. Gustav Scheuthauer (1832–1894) became Arányi’s successor. Each of them continued to keep contact with their tutors in Vienna, especially with Karl Rokitansky, and followed the clinicopathological conception pioneered by the Vienna Medical School regarding diagnostics, treatment and prevention of diseases. Two physicians remained in Vienna: Mór Kaposi (1837–1902), who became known worldwide posthumously due to the connection between Kaposi’s sarcoma and AIDS, was the director of the Department of Dermatology of the Vienna University in 1878. Salomon Stricker (1837–1898) undertook the leadership of the Department of General and Experimental Pathology in 1872.
- Open Access
- 21 March 2021
- Published by Springer Nature in BMC Surgery
- Vol. 21 (1) , 1-8
Double rarity: malignant masquerade biliary stricture in a situs inversus totalis patient
Background: Situs inversus totalis is a rare anatomical variation of both the thoracic and the abdominal organs. Common bile duct strictures can be caused by malignant and benign diseases as well. 7–18% of the latter ones are 'malignant masquerade’ cases, as pre-operative differentiation is difficult. Case presentation: We present the case of a 68y male patient with known situs inversus totalis and a recent onset of obstructive jaundice caused by a malignant behaving common bile duct stricture. Technically difficult endoscopic retrograde cholangiopancreatography, brush cytology, magnetic resonance cholangiopancreatography, endoscopic ultrasound, and percutaneous transhepatic drainage with stent implantation were performed for proper diagnosis. Cholecystectomy, common bile duct resection with hilar lymphadenectomy, and hepatico-jejunostomy have been performed following multidisciplinary consultation. The final histology report did not confirm any clear malignancy, the patient is doing well. Conclusion: In situs inversus patients, both diagnostic and therapeutic procedures can lead to various difficulties. Benign biliary strictures are frequently misdiagnosed preoperatively as cholangiocellular carcinoma. Surgery is usually unavoidable, involving a significant risk of complications. The co-existence of these two difficult diagnostic and therapeutic features made our case challenging.
- 21 March 2021
- Published by Springer Nature in BMC Surgery
- Vol. 21 (1) , 1-8
Open AccessDouble rarity: malignant masquerade biliary stricture in a situs inversus totalis patient
Background: Situs inversus totalis is a rare anatomical variation of both the thoracic and the abdominal organs. Common bile duct strictures can be caused by malignant and benign diseases as well. 7–18% of the latter ones are 'malignant masquerade’ cases, as pre-operative differentiation is difficult. Case presentation: We present the case of a 68y male patient with known situs inversus totalis and a recent onset of obstructive jaundice caused by a malignant behaving common bile duct stricture. Technically difficult endoscopic retrograde cholangiopancreatography, brush cytology, magnetic resonance cholangiopancreatography, endoscopic ultrasound, and percutaneous transhepatic drainage with stent implantation were performed for proper diagnosis. Cholecystectomy, common bile duct resection with hilar lymphadenectomy, and hepatico-jejunostomy have been performed following multidisciplinary consultation. The final histology report did not confirm any clear malignancy, the patient is doing well. Conclusion: In situs inversus patients, both diagnostic and therapeutic procedures can lead to various difficulties. Benign biliary strictures are frequently misdiagnosed preoperatively as cholangiocellular carcinoma. Surgery is usually unavoidable, involving a significant risk of complications. The co-existence of these two difficult diagnostic and therapeutic features made our case challenging.
- Open Access
- 7 February 2021
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 162 (6) , 227-232
Egy különleges pancreaselváltozás: kevert differenciációjú nodularitás és diffúz szigetsejtes hyperplasia
Összefoglaló. A szerzők egy különleges pancreaselváltozás esetét ismertetik, melyben az acinusok neuroendokrin jellegű transzformációja diffúz, atípusos megjelenésű szigetsejtes hyperplasiával társult, valamint a pancreas mindhárom sejtvonalát (acinaris, ductalis, insularis) tartalmazó nodulusok képződtek. A komplex megjelenés ellenére a kórfolyamat nem járt endokrin tünetekkel. Esetünkben a kiváltó ok hátterében a struktúrák kóros progenitorsejt-differenciációja állhatott. Az irodalomban ilyen közlés eddig nem ismert. Orv Hetil. 2021; 162(6): 227–232. Summary. The authors present a case of a peculiar pancreatic lesion, in which the neuroendocrine transformation of the acini was associated with a diffuse, atypical insular hyperplasia, and micronodules exhibiting trilineage differentiation. Despite the complex alteration, no endocrine symptoms were noted. The case may represent the result of an abnormal pancreatic differentiation raising the possibility of reprogramming of the progenitor cells. To the best of our knowledge, this is the first report of such a lesion in the literature. Orv Hetil. 2021; 162(6): 227–232.
- 7 February 2021
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 162 (6) , 227-232
Open AccessEgy különleges pancreaselváltozás: kevert differenciációjú nodularitás és diffúz szigetsejtes hyperplasia
Összefoglaló. A szerzők egy különleges pancreaselváltozás esetét ismertetik, melyben az acinusok neuroendokrin jellegű transzformációja diffúz, atípusos megjelenésű szigetsejtes hyperplasiával társult, valamint a pancreas mindhárom sejtvonalát (acinaris, ductalis, insularis) tartalmazó nodulusok képződtek. A komplex megjelenés ellenére a kórfolyamat nem járt endokrin tünetekkel. Esetünkben a kiváltó ok hátterében a struktúrák kóros progenitorsejt-differenciációja állhatott. Az irodalomban ilyen közlés eddig nem ismert. Orv Hetil. 2021; 162(6): 227–232. Summary. The authors present a case of a peculiar pancreatic lesion, in which the neuroendocrine transformation of the acini was associated with a diffuse, atypical insular hyperplasia, and micronodules exhibiting trilineage differentiation. Despite the complex alteration, no endocrine symptoms were noted. The case may represent the result of an abnormal pancreatic differentiation raising the possibility of reprogramming of the progenitor cells. To the best of our knowledge, this is the first report of such a lesion in the literature. Orv Hetil. 2021; 162(6): 227–232.
- Open Access
- 19 July 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (14) , 5100
Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro
The poor outcome of pancreas ductal adenocarcinomas (PDAC) is frequently linked to therapy resistance. Modulated electro-hyperthermia (mEHT) generated by 13.56 MHz capacitive radiofrequency can induce direct tumor damage and promote chemo- and radiotherapy. Here, we tested the effect of mEHT either alone or in combination with radiotherapy using an in vivo model of Panc1, a KRAS and TP53 mutant, radioresistant PDAC cell line. A single mEHT shot of 60 min induced ~50% loss of viable cells and morphological signs of apoptosis including chromatin condensation, nuclear shrinkage and apoptotic bodies. Most mEHT treatment related effects exceeded those of radiotherapy, and these were further amplified after combining the two modalities. Treatment related apoptosis was confirmed by a significantly elevated number of annexin V single-positive and cleaved/activated caspase-3 positive tumor cells, as well as sub-G1-phase tumor cell fractions. mEHT and mEHT+radioterapy caused the moderate accumulation of γH2AX positive nuclear foci, indicating DNA double-strand breaks and upregulation of the cyclin dependent kinase inhibitor p21waf1 besides the downregulation of Akt signaling. A clonogenic assay revealed that both mono- and combined treatments affected the tumor progenitor/stem cell populations too. In conclusion, mEHT treatment can contribute to tumor growth inhibition and apoptosis induction and resolve radioresistance of Panc1 PDAC cells.
- 19 July 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (14) , 5100
Open AccessModulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro
The poor outcome of pancreas ductal adenocarcinomas (PDAC) is frequently linked to therapy resistance. Modulated electro-hyperthermia (mEHT) generated by 13.56 MHz capacitive radiofrequency can induce direct tumor damage and promote chemo- and radiotherapy. Here, we tested the effect of mEHT either alone or in combination with radiotherapy using an in vivo model of Panc1, a KRAS and TP53 mutant, radioresistant PDAC cell line. A single mEHT shot of 60 min induced ~50% loss of viable cells and morphological signs of apoptosis including chromatin condensation, nuclear shrinkage and apoptotic bodies. Most mEHT treatment related effects exceeded those of radiotherapy, and these were further amplified after combining the two modalities. Treatment related apoptosis was confirmed by a significantly elevated number of annexin V single-positive and cleaved/activated caspase-3 positive tumor cells, as well as sub-G1-phase tumor cell fractions. mEHT and mEHT+radioterapy caused the moderate accumulation of γH2AX positive nuclear foci, indicating DNA double-strand breaks and upregulation of the cyclin dependent kinase inhibitor p21waf1 besides the downregulation of Akt signaling. A clonogenic assay revealed that both mono- and combined treatments affected the tumor progenitor/stem cell populations too. In conclusion, mEHT treatment can contribute to tumor growth inhibition and apoptosis induction and resolve radioresistance of Panc1 PDAC cells.